Rhythm Pharmaceuticals, Inc. (RYTM)

Rhythm Pharmaceuticals Revenue

Rhythm Pharmaceuticals had revenue of $60.11M in the quarter ending March 31, 2026, with 83.81% growth. This brings the company's revenue in the last twelve months to $217.17M, up 58.67% year-over-year. In the year 2025, Rhythm Pharmaceuticals had annual revenue of $189.76M with 45.83% growth.

• Revenue (ttm): $217.17M
• Revenue Growth: +58.67%
• P/S Ratio: 28.59
• Revenue / Employee: $524,553
• Employees: 414
• Market Cap: 6.21B

Revenue History

Fiscal Year End	Revenue	Change	Growth
Dec 31, 2025	189.76M	59.63M	45.83%
Dec 31, 2024	130.13M	52.70M	68.06%
Dec 31, 2023	77.43M	53.79M	227.56%
Dec 31, 2022	23.64M	20.48M	649.46%
Dec 31, 2021	3.15M	-	-

Data Source: S&P Global Market Intelligence Last updated: May 5, 2026

Revenue data is provided by S&P Global Market Intelligence and updates within hours after each earnings release, which is every three months for this company.

Update frequency:

Quarterly

Last checked:

May 16, 2026

Data Sources Report a data error